Abstract
For specific targeting of HER2 and triggered drug release by stimuli-responsive conformational transformation, we developed a dual-functional cyclic peptide gatekeeper containing a HER2-binding sequence on the surface of mesoporous nanocontainers.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have